Patients Stopping Weight-Loss Injections Gain Back Weight Far More Rapidly Compared to People Using Diet and Exercise

New research suggests that individuals who come off blockbuster slimming jabs like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who halt conventional lifestyle plans.

Published data in a prominent health publication shows that while overweight individuals frequently drop about a fifth of their body weight while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month after stopping.

"People using such medications need to be informed of the potential of rapid rebound weight gain when the medication is stopped," warns expert Dr. Susan Jebb.

This pace of regain suggests a reversion to pre-treatment weight in about a year and a half.

Weighing Approaches

The study, which looked at 37 of studies involving thousands of patients, contrasted the effects of GLP-1 agonists with other pills.

Researchers point out that people who shed pounds through dieting generally see a less rapid creep back—approximately 0.1 kg a month—post-intervention.

The Reason for the Quick Regain

Experts propose the way of the jabs is key to understanding the heightened regain.

These medications mimic a natural hormone called GLP-1, which helps regulate appetite.

"Long-term administration of the hormone concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.

"Stopping of this GLP-1 'fix' results in appetite is no longer kept in check, making excessive eating far more likely."

An Ongoing Condition?

Health authorities advise the jabs for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.

A number of clinicians say that, due to the significant potential of relapse, the treatment might need to be ongoing.

This opinion is reinforced by drug manufacturers, who say that the findings "underscore the long-term nature of excess weight," comparing it to managing conditions like hypertension.

User Accounts

Users who have stopped the jabs report a intense resurgence of hunger.

"It felt as if something activating and you're instantly extremely hungry," described one woman.

This challenge is compounded if users have not adopted permanent dietary or behavioural changes during therapy.

Significant Use

Survey data suggest that millions of people in the UK have used these injections in the last 12 months, with interest remaining high.

• Adoption is more common among women compared to males.
• The 40s and 50s demographic shows the greatest level of interest.
• Many access the drugs through private healthcare rather than the NHS.

Ultimately, experts emphasize that while the jabs are powerful tools for shedding pounds, they are not a magic cure and long-term success hinges on ongoing lifestyle changes.